Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

SoftOx Solutions AS Regulatory Filings 2021

Dec 17, 2021

3747_rns_2021-12-17_fffe48c0-2d1a-45b3-811f-ad7ad9d9c7fd.html

Regulatory Filings

Open in viewer

Opens in your device viewer

SoftOx Solutions AS: Notice of extraordinary general meeting

SoftOx Solutions AS: Notice of extraordinary general meeting

Notice is hereby given of an extraordinary general meeting of SoftOx Solutions AS (the "Company") to be held on the 29 December 2021 at 10:00.

Pursuant to section 5-8 of the Norwegian Private Limited Liability Companies Act and due to the ongoing COVID-19 pandemic, the extraordinary general meeting will be held as a video conference meeting without physical attendance for the shareholders. Shareholders who wish to participate electronically must send a notice of attendance to the Company by 28 December 2021 at 12:00 in accordance with the attached notice of attendance form. Details for the video conference meeting will only be provided to shareholders who have given notice in advance.

For further information, please contact:

CEO Geir Almås of SoftOx Solutions AS, or

CFO Kristine Mundal Rød of SoftOx Solutions AS

Mail: [email protected]

Mobile: (+47) 948 59 599

About SoftOx Solutions AS

SoftOx Solutions AS (SoftOx, listed on Euronext Growth Oslo) is a Norwegian

BioTech company based in Oslo with the aim of helping to combat major threats to

human health, namely the emergence of antimicrobial resistance (AMR), biofilm

infections in chronic wounds and the spread of viruses. For more information on

SoftOx, visit www.soft-ox.com